In the News


New York Times

New Therapy for Aggressive Prostate Cancer Improves Survival – New York Times, June 24, 2021
Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy – April 26, 2018


Tulane’s Coverage of Dr. Sartor’s Research

Molecularly targeted radiation therapy extends survival for patients with advanced prostate cancer – June 3, 2021
Study targeting tumor genetic mutations yields ‘practice changing’ results for prostate cancer treatment – May 13, 2020
Study Finds Genetic Risks Associated with Prostate Cancer Are Underestimated – February 7, 2019
Shades of Bluedoo – September 17, 2018
Tulane Cancer Center to Host Free Prostate Cancer Seminar – August 24, 2018
Tulane Hosts Fifth Annual NOLA Bluedoo Run – August 16, 2018
Tulane oncologist outlines prostate cancer treatment advances in New England Journal of Medicine – February 8, 2018
Blue chippers – October 2, 2017
Tulane Cancer Center hosts fourth annual NOLA Bluedoo Run – September 22, 2017
Man UP! event offers free prostate cancer screenings – September 1, 2017
Prostate cancer immunotherapy works better for African-American men – May 15, 2017
Leading Study Backs Hormone Therapy With Radiation for Recurrent Prostate Cancer – February 3, 2017
Tulane Cancer Center to Host Free Prostate Cancer Seminar – September 2, 2016
Popular prostate cancer therapy may be harmful – October 22, 2014
Tulane major player in FDA approval of new drug for advanced prostate cancer – May 28, 2013
Tulane Cancer Researcher leads trial for promising prostate cancer therapy – March 04, 2010
Drug May Extend Life for Prostate Cancer Patients – March 03, 2010
Halting Men’s Most Common Cancer – November 23, 2009
Tulane Cancer Center To Begin Novel Clinical Trial for Late-Stage Prostate Cancer Drug – November 16, 2009
Free Cancer Screenings Help Men Take Charge of Health – August 06, 2008
Major Player Joins Prostate Cancer Team – ch 13, 2008


Outside Media Coverage of Dr. Sartor’s Research

Dr. Sartor on the Significance of the REASSURE Trial in Mcrpc – OncLive, July 10, 2020
Dr. Sartor on Outcomes With 177Lu-PSMA-617 After Radium 223 in Mcrpc – OncLive, June 18, 2020
Dr. Sartor on Sequential use of Beta and Alpha Emitters in Mcrpc – OncLive, June 17, 2020
Dr. Sartor on Implications of PSMA-PET Positivity in Prostate Cancer – OncLive, March 30, 2020
Dr. Sartor discusses recent outcomes investigating Lu-177–PSMA in patients with APC – Youtube, February 21, 2020
Dr. Sartor on Emerging Agents in Prostate Cancer – OncLive, February 5, 2020
Dr. Sartor on Promising Treatment Approaches in Prostate Cancer – OncLive, January 24, 2020
Dr. Sartor on the VISION Trial in mCRPC – OncLive, November 15, 2019
Sumanta K. Pal, MD, and A. Oliver Sartor, MD, on Prostate Cancer: Perspectives on Outcomes for Black and White Patients – ASCO Post 2018
Oliver Sartor, MD, on Issues in Immunotherapy – ASCP Post 2018
ASCO Preview: Cabazitaxel, Survival Surrogate Endpoints in Prostate Cancer – CancerNetwork, June 1, 2016
Dr. Sartor Talks About the Tulane Cancer Center Prostate Cancer Research Program—YouTube, April 2014
Dr. Sartor Discusses Custirsen as Treatment for Prostate Cancer—Targeted Oncology, April 10, 2014
Dr. Sartor on Provenge in Combination with Radium-223—OncLiveTV, April 1, 2014
Dr. Sartor Discusses PSA Testing Guidelines—Targeted Oncology, March 27, 2014
Dr. Sartor Discusses PSA Testing for Prostate Cancer—OncLiveTV, March 17, 2014
Decade of Wisdom: A. Oliver Sartor, M.D.— 2014 Genitourinary Cancers Symposium, January 31, 2014
An Update on New Therapies for mCRPC: An Interview with Oliver Sartor M.D.—Renal & Urology News, September 13, 2013
Dr. Sartor on Progress for the Treatment of Prostate Cancer—OncLiveTV, September 3, 2013
Dr. Sartor on the Mechanism of Action of Radium-223—OncLiveTV, July 9, 2013 28, 2013
Dr. Sartor on Recent Progress on the Molecular Front for the Treatment of Prostate Cancer—Targeted Oncology, June 26, 2013
Surveillance for Prostate Cancer: Are the Proceduralists Running Amok? – Cancer Network, June 11, 2013
New Hope in the Battle Against Prostate Cancer –, May 28, 28, 2013
Should Men Get PSA Tests to Screen for Prostate Cancer? – Wall Street Journal – February 14, 2013
Dr. Oliver Sartor Discusses PSA Screening – OncLiveTV, May 22, 2012
Dr. Oliver Sartor Discusses a New Prostate Cancer Trial Combining Radium-223 and Provenge—OncLiveTV, April 12, 2012
Dr. Oliver Sartor Discusses Radium-223 in Early Prostate Cancer—OncLiveTV, April 4, 2012
Thought Leader Conversations with A. Oliver Sartor, M.D.—Institute for Medical Education & Research (IMER), February 13, 2012
Experimental Drugs Do Battle Against Advanced Prostate Cancer—U.S. News & World Report, February 1, 2012
Dr. Sartor on Patients in the ALSYMPCA Radium-223 Trial—OncLiveTV, December 20, 2011
Dr. Sartor Discusses Prostate Cancer Drug Combinations—OncLiveTV, November 29, 2011
Dr. Sartor Discusses the Novel Agent Radium-223—OncLiveTV, November 15, 2011
Taxanes: Pivotal Agents in the Management of Metastatic Castration-Resistant Prostate Cancer, June 2, 2011
Cancer Experts Brand Lockerbie Bomber Release “Ridiculous” – The Telegraph, September 2010
United States Senate Committee on Foreign Relations – Testimony of Dr. Oliver Sartor, September 29, 2010
Searching For a Miracle Cure (Oliver Sartor, MD) – New Orleans Magazine, August 2010
Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review—GoodNews Broadcast, July 23, 2010
Drugs Help Men With Advanced Prostate Cancer – WWL-TV Channel 6, July 6, 2010
Men Have Hormones Too – Men’s Health, May 5, 2010
Positive Test for Sanofi Prostate Cancer Drug – New York Times, March 3, 2010
Leading Study Backs Hormone Therapy With Radiation for Recurrent Prostate Cancer – Tulane University New Wave – February 2017
Dr. Oliver Sartor on Considerations, Controversy With PSA Testing in Prostate Cancer – Targeted Oncology – May 2016
Popular Prostate Cancer Therapy May be Harmful – Medical XPress – October 2014